Results 161 to 170 of about 7,752 (219)
Some of the next articles are maybe not open access.
Safety Profile of the Triptans
Expert Opinion on Drug Safety, 2003The triptans are 5-HT(1B/1D) agonists used as migraine and cluster-specific agents. Seven are in commercial use worldwide; in order of release these are sumatriptan, zolmitriptan, rizatriptan, naratriptan, almotriptan, frovatriptan and eletriptan. Sumatriptan has been in clinical use since 1991, and although postmarketing studies have stimulated much ...
David Millson, Stewart J Tepper
exaly +3 more sources
The American Journal of Medicine Supplements, 2005
The debilitating effect of migraine has fueled the search for more specific agents to treat its characteristic and associated symptoms. Second-generation oral triptans have shown an improved efficacy profile in comparison with the pioneer sumatriptan and with the over-the-counter medications and prescription analgesics that have been staples of ...
Ninan T, Mathew, Elizabeth W, Loder
openaire +2 more sources
The debilitating effect of migraine has fueled the search for more specific agents to treat its characteristic and associated symptoms. Second-generation oral triptans have shown an improved efficacy profile in comparison with the pioneer sumatriptan and with the over-the-counter medications and prescription analgesics that have been staples of ...
Ninan T, Mathew, Elizabeth W, Loder
openaire +2 more sources
Use of almotriptan in triptan-experienced and triptan-naïve patients
Current Medical Research and Opinion, 2007To evaluate the efficacy of oral almotriptan 12.5 mg as an acute treatment for migraine with a focus on triptan-experienced versus triptan-naïve patients.Four recent Almirall-sponsored clinical trials of oral almotriptan 12.5 mg in acute migraine, in which data regarding previous acute therapy were collected, are reviewed.
Julio, Pascual, Hans-Christoph, Diener
openaire +2 more sources
Triptans: Are they all the same?
Current Pain and Headache Reports, 2002The triptans have provided a major advance in the treatment of the pain and disability associated with migraine headache. With seven triptans in use or in clinical development, the clinician is faced with the decision of which triptan to prescribe to the patient with migraine.
Tamara, Pringsheim, Marek, Gawel
openaire +2 more sources
Triptans: Low Utilization and High Turnover in the General Population
Cephalalgia, 2010 Studies performed in selected populations have shown a poor utilization of triptans for migraine. Our study was aimed at establishing patterns of triptans utilization in a large community using the pharmaceutical prescriptions database of two consecutive
Michela Franchini
exaly +2 more sources
New England Journal of Medicine, 2010
A 23-year-old woman presents with migraine headaches that are unresponsive to analgesics. Triptan therapy is recommended. Triptans are serotonin agonists that were originally thought to provide migraine relief by causing cranial vasoconstriction; other mechanisms are now also proposed.
Amer A, Alkhatib, Fateh A, Elkhatib
openaire +5 more sources
A 23-year-old woman presents with migraine headaches that are unresponsive to analgesics. Triptan therapy is recommended. Triptans are serotonin agonists that were originally thought to provide migraine relief by causing cranial vasoconstriction; other mechanisms are now also proposed.
Amer A, Alkhatib, Fateh A, Elkhatib
openaire +5 more sources
Headache: The Journal of Head and Face Pain, 2006
Objective.—To evaluate triptan use patterns in a large Israeli HMO district. Background.—Triptans, 5HT 1B/1D agonists, provide an effective and safe relief of headache and accompanying symptoms during an acute migraine attack.
Gal, Ifergane +2 more
openaire +2 more sources
Objective.—To evaluate triptan use patterns in a large Israeli HMO district. Background.—Triptans, 5HT 1B/1D agonists, provide an effective and safe relief of headache and accompanying symptoms during an acute migraine attack.
Gal, Ifergane +2 more
openaire +2 more sources
Neurological Sciences, 2012
Migraine is a chronic, recurrent, disabling condition that affects millions of people worldwide. Proper acute care treatment for migraineurs is based on triptans, a class of specific medications approved over 20 years ago. Triptans are serotonin (5-HT1B/1D) receptor agonists that are generally effective, well tolerated and safe.
D, Cologno +6 more
openaire +2 more sources
Migraine is a chronic, recurrent, disabling condition that affects millions of people worldwide. Proper acute care treatment for migraineurs is based on triptans, a class of specific medications approved over 20 years ago. Triptans are serotonin (5-HT1B/1D) receptor agonists that are generally effective, well tolerated and safe.
D, Cologno +6 more
openaire +2 more sources
Drug Safety, 2003
The triptans represent a relatively new class of compounds effective in the treatment of migraine. The safety and tolerability of these drugs have been extensively investigated since the first triptan (sumatriptan) became commercially available. A report on a very large population of patients tested during clinical trials and in postmarketing studies ...
NAPPI, GIUSEPPE +2 more
openaire +2 more sources
The triptans represent a relatively new class of compounds effective in the treatment of migraine. The safety and tolerability of these drugs have been extensively investigated since the first triptan (sumatriptan) became commercially available. A report on a very large population of patients tested during clinical trials and in postmarketing studies ...
NAPPI, GIUSEPPE +2 more
openaire +2 more sources
Current Pain and Headache Reports, 2002
Headache care specialists agree that the introduction of sumatriptan constitutes a major advance in headache therapy, but they differ about whether other triptans offer clinically significant advantages over sumatriptan. This article examines this issue by considering the similarities and differences among triptans.
Reijo, Salonen, Andrew, Scott
openaire +2 more sources
Headache care specialists agree that the introduction of sumatriptan constitutes a major advance in headache therapy, but they differ about whether other triptans offer clinically significant advantages over sumatriptan. This article examines this issue by considering the similarities and differences among triptans.
Reijo, Salonen, Andrew, Scott
openaire +2 more sources